News & Updates

Show Multimedia Only

Standardized workflow improves outcomes in children admitted for abdominal pain

03 Aug 2023 by

A quality improvement (QI) project consisting of a standardized management workflow with stringent discharge criteria for paediatric abdominal pain admissions at KK Women’s and Children’s Hospital in Singapore has resulted in reduced length of stay (LOS), number of unnecessary investigations, and variability in investigations ordered, without causing misdiagnosis, reports a study.

Standardized workflow improves outcomes in children admitted for abdominal pain

03 Aug 2023

Cannabidiol beneficial to patients with gastroparesis

28 Jul 2023

For patients with gastroparesis, the use of cannabidiol (CBD) provides symptom relief and improves the tolerance of liquid nutrient intake, despite a delay in gastric emptying of solids (GES), as shown in a study.

Cannabidiol beneficial to patients with gastroparesis

28 Jul 2023

Novel risk score predicts 1-year mortality in GI bleeding

26 Jul 2023

A new scoring system that incorporates the use of antithrombotic (AT) drugs upon admission can accurately predict mortality in patients with overt gastrointestinal bleeding (GIB) at 1 year, reports a recent study.

Novel risk score predicts 1-year mortality in GI bleeding

26 Jul 2023

Vedolizumab lowers risk of severe CDI in patients with ulcerative colitis

25 Jul 2023

Treatment with vedolizumab is associated with a reduced adjusted risk of severe Clostridioides difficile infection (CDI), but not total CDI, in patients with ulcerative colitis (UC), reports a study. Additionally, cytomegalovirus colitis (CMVC) is not seen in those who initiated vedolizumab.

Vedolizumab lowers risk of severe CDI in patients with ulcerative colitis

25 Jul 2023

Mycophenolate mofetil prompts remission better than azathioprine in autoimmune hepatitis

20 Jul 2023 by

Among patients with treatment-naïve autoimmune hepatitis, more of those who receive mycophenolate mofetil achieve remission than those who receive azathioprine, as shown in the results of the CAMARO trial.

Mycophenolate mofetil prompts remission better than azathioprine in autoimmune hepatitis

20 Jul 2023

Rotavirus infection linked to gastroenteritis, neurological complications in children

20 Jul 2023

Children with rotavirus infection are at risk of developing gastroenteritis with severe but self-limiting neurological manifestations, reveals a study.

Rotavirus infection linked to gastroenteritis, neurological complications in children

20 Jul 2023

Resmetirom delivers improved outcomes for NASH patients with fibrosis

19 Jul 2023 by

The THR-β selective agonist resmetirom helps resolve nonalcoholic steatohepatitis (NASH) and reduce fibrosis, with the drug being safe and well-tolerated, according to data from the large phase III pivotal MAESTRO-NASH trial presented at EASL 2023.

Resmetirom delivers improved outcomes for NASH patients with fibrosis

19 Jul 2023

Anti-obesity therapies go beyond weight loss

19 Jul 2023 by

Weight loss strategies do not only provide therapeutic alternatives for obesity but may also hold promise in the management of type 2 diabetes (T2D) and NAFLD*.

Anti-obesity therapies go beyond weight loss

19 Jul 2023

Phase III data support long-term efficacy of TAF against HBV

18 Jul 2023 by

Two phase III studies presented at EASL 2023 reflected the long-term efficacy of tenofovir alafenamide (TAF) for individuals with HBeAg*-positive and HBeAg-negative chronic hepatitis B virus (HBV).

Phase III data support long-term efficacy of TAF against HBV

18 Jul 2023

Mepolizumab does little to improve dysphagia symptoms

17 Jul 2023

Mepolizumab does not appear to reduce the symptoms of dysphagia as compared with placebo in the treatment of individuals with eosinophilic oesophagitis (EoE), although the drug helps reduce eosinophil counts and endoscopic severity, according to a study.

Mepolizumab does little to improve dysphagia symptoms

17 Jul 2023

News & Updates

Filter by Specialty:

Specialty:

Standardized workflow improves outcomes in children admitted for abdominal pain

Standardized workflow improves outcomes in children admitted for abdominal pain

Cannabidiol beneficial to patients with gastroparesis

Cannabidiol beneficial to patients with gastroparesis

Novel risk score predicts 1-year mortality in GI bleeding

Novel risk score predicts 1-year mortality in GI bleeding

Vedolizumab lowers risk of severe CDI in patients with ulcerative colitis

Vedolizumab lowers risk of severe CDI in patients with ulcerative colitis

Mycophenolate mofetil prompts remission better than azathioprine in autoimmune hepatitis

Mycophenolate mofetil prompts remission better than azathioprine in autoimmune hepatitis

Rotavirus infection linked to gastroenteritis, neurological complications in children

Rotavirus infection linked to gastroenteritis, neurological complications in children

Resmetirom delivers improved outcomes for NASH patients with fibrosis

Resmetirom delivers improved outcomes for NASH patients with fibrosis

Anti-obesity therapies go beyond weight loss

Anti-obesity therapies go beyond weight loss

Phase III data support long-term efficacy of TAF against HBV

Phase III data support long-term efficacy of TAF against HBV

Mepolizumab does little to improve dysphagia symptoms

Mepolizumab does little to improve dysphagia symptoms